Market Overview

UPDATE: Oppenheimer Upgrades UnitedHealth Group to Outperform; Valuation is Overly Pessimistic

Share:
Related UNH
Leerink Sees Humana Takeout At $220/Share Or More
Sterne Agee CRT Upgrades UnitedHealth Group To Buy
The Best Way To Judge Past Performance: Part 2 (Seeking Alpha)

Oppenheimer upgraded UnitedHealth Group (NYSE: UNH) from Perform to Outperform and raises the price target from $63.00 to $66.00.

Oppenheimer commented, "We believe that UNH's current discounted multiples appear attractive in light of the overly-pessimistic outlook regarding the impact of the ACA, and the recent pull-back related to MA rates. Furthermore, following the Q4:12 earnings conference call, we have increased confidence that FY2013 results will outperform expectations. With strong cash flow, a well-diversified portfolio and a strong track record of performance, we would be buyers of UNH."

UnitedHealth Group closed at $55.21 on Wednesday.

Latest Ratings for UNH

DateFirmActionFromTo
Jun 2015Sterne Agee CRTUpgradesNeutralBuy
Jun 2015RBC CapitalInitiates Coverage onOutperform
Apr 2015BarclaysMaintainsOverweight

View More Analyst Ratings for UNH
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Upgrades Analyst Ratings

 

Related Articles (UNH)

Around the Web, We're Loving...

Get Benzinga's Newsletters